Van Berkel T J, Koster J F, Hülsmann W C
Biochim Biophys Acta. 1977 Mar 25;486(3):586-9. doi: 10.1016/0005-2760(77)90114-x.
The capacity of the homogenates from human liver, rat parenchymal cells, rat non-parenchymal cells and total rat liver for the breakdown of human and rat high density lipoprotein (HDL) and human low density lipoprotein (LDL) was determined. Human HDL was catabolized by human liver, in contrast to human LDL, the protein degradation of which was low or absent. Human and rat HDL were catabolized by both the rat parenchymal and non-parenchymal cell homogenates with, on protein base, a 10-times higher activity in the non-parenchymal liver cells. This implies that more than 50% of the total liver capacity for HDL protein degradation is localized in these cell types. Human LDL degradation in the rat could only be detected in the non-parenchymal cell homogenates. These findings are discussed in view of the function of HDL and LDL as carriers for cholesterol.
测定了人肝脏、大鼠实质细胞、大鼠非实质细胞以及大鼠全肝匀浆对人及大鼠高密度脂蛋白(HDL)和人低密度脂蛋白(LDL)的分解能力。与人类LDL不同,人类HDL可被人肝脏分解代谢,人类LDL的蛋白质降解程度较低或不存在。大鼠实质细胞和非实质细胞匀浆均可分解代谢人和大鼠的HDL,以蛋白质为基础,非实质肝细胞中的活性高10倍。这意味着肝脏HDL蛋白质降解总能力的50%以上存在于这些细胞类型中。仅在大鼠非实质细胞匀浆中检测到大鼠对人LDL的降解。鉴于HDL和LDL作为胆固醇载体的功能,对这些发现进行了讨论。